Contact Information
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Anne M. Connolly
Biography
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic. Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Neurology
Division Chief
Neurology Residency
Faculty
Clinical Neurophysiology Fellowship
Faculty
Center for Gene Therapy
Associate Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Research
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials. Publications
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Anne M. Connolly
Biography
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic. Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Neurology
Division Chief
Neurology Residency
Faculty
Clinical Neurophysiology Fellowship
Faculty
Center for Gene Therapy
Associate Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Research
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials. Publications
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Anne M. Connolly
Contact Information
- Call us at:
- (614) 722-4625
- Fax us at:
- (614) 722-4633
- PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Anne M. Connolly
Biography
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic. Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Biography
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic. Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Biography
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic. Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic. Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders. At Nationwide Children’s, she leads the Spinal Muscular Atrophy Clinic.
Dr. Connolly has published 104 peer-reviewed articles, 18 invited reviews and chapters and given more than 50 invited lectures. She is associate editor for the Journal of Child Neurology. In addition, she has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society, the World Muscle Society and the International Child Neurology Society.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
- Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Neurology
Division Chief
Neurology Residency
Faculty
Clinical Neurophysiology Fellowship
Faculty
Center for Gene Therapy
Associate Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Academic and Clinical Areas
Neurology
Division Chief
Neurology Residency
Faculty
Clinical Neurophysiology Fellowship
Faculty
Center for Gene Therapy
Associate Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Academic and Clinical Areas
Neurology
Division Chief
Neurology Residency
Faculty
Clinical Neurophysiology Fellowship
Faculty
Center for Gene Therapy
Associate Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Neurology
Division Chief
Neurology Residency
Faculty
Clinical Neurophysiology Fellowship
Faculty
Center for Gene Therapy
Associate Faculty
Primary Department
Pediatrics
Primary Section
Neurology
- Neurology
- Division Chief
- Neurology Residency
- Faculty
- Clinical Neurophysiology Fellowship
- Faculty
- Center for Gene Therapy
- Associate Faculty
- Primary Department
- Pediatrics
- Primary Section
- Neurology
Research
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials. Publications
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
Research
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials. Publications
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
Research
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials. Publications
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials. Publications
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
Lab(s)
Center for Gene Therapy
An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between autoantibodies and childhood neurological disorders. She also studied the natural history and effects of treatment of mouse models of Duchenne muscular dystrophy (DMD) and congenital muscular dystrophy (CMD). She has also helped develop outcome measures for infants and boys with DMD and has led or been a collaborator in numerous pivotal clinical trials.
Lab(s)
Center for Gene Therapy
Center for Gene Therapy
Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657. Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225. Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858. Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20; Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
View More Publications
- Connolly AM, Zaidman CM, Golumbek PT, Cradock MM, Flanigan KM, Kuntz NL, Finkel RS, McDonald CM, Iannaccone ST, Anand P, Siener CA, Florence JM, Lowes LP, Alfano LN, Johnson LB, Nicorici A, Nelson LL, Mendell JR, MDA DMD Clinical Research Network.. Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2019 Jun; 59: 650-657.
- Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, Alfano LN, Connolly AM, Jay C, Polari H, Ciafaloni E, Qi M, Griggs RC, Gatheridge MA. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019 Jun; 15: 219-225.
- Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore). 2019 Jun; 98: e15858.
- Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. JAMA Neurol. 2019 May 20;
- Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019; 6: 31-41.
Education
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
Education
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
Education
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
Date of Appointment at Nationwide Children’s Hospital: 04/01/2019
Board Certifications
Child Neurology Clinical Neuromuscular Pathology Electrodiagnostic Medicine
Fellowship
Washington University School of Medicine
Date Completed: 06/30/1993
Fellowship
National Institute of Mental Health
Date Completed: 06/30/1991
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1990
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1988
Residency
St. Louis Children’s Hospital
Date Completed: 06/30/1987
Medical School
Indiana University-Purdue University Indianapolis
Date Completed: 03/31/1984
- Child Neurology
- Clinical Neuromuscular Pathology
- Electrodiagnostic Medicine
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-4625
- Fax us at:
- (614) 722-4633
- Neurology700 Children’s DrColumbus, OH 43205 (map)
